BINDING OF ARYLPIPERAZINES TO 5-HT3 SEROTONIN RECEPTORS - RESULTS OF A STRUCTURE-AFFINITY STUDY
BINDING OF ARYLPIPERAZINES TO 5-HT3 SEROTONIN RECEPTORS - RESULTS OF A STRUCTURE-AFFINITY STUDY
复制标题
DOI:
10.1016/0014-2999(89)90802-9
复制
发表时间:
1989-09-22
影响因子:
5
通讯作者:
PEROUTKA, SJ
中科院分区:
文献类型:
--
作者:
GLENNON, RA;ISMAIEL, AEM;PEROUTKA, SJ
The binding affinities of a series of arylpiperazine derivatives at [3H]quipazine-labeled central 5-HT3 sites were investigated. Features determined to be important for binding include the N4 piperazine nitrogen atom (but not the N1 piperazine nitrogen), and quinolinyl group. The quinoline nitrogen atom of quipazine also contributes to affinity and its replacement by carbon reduces affinity by 20-fold. The entire quinoline nucleus is not necessary for binding, and certain monocyclic arylpiperazines, particularly those with a chloro group meta to the position of the piperazine ring (e.g. mCPP, MK-212), also bind at 5-HT3, sites; however, the affinities of these agents are at least an order of magnitude less that that of quipazine itself. Taking advantage of the fact that the tertiary amines are not well tolerated at 5-HT1B sites, but that N-methyl substituents have little effect on 5-HT3 binding, we designed and synthesized a tertiary amine analog of quipazine, i.e., N-methylquipazine (NMQ). NMQ binds at 5-HT3 sites with an affinity similar to that of quipazine; however, unlike quipazine, NMQ shows very little affinity (IC50 > 10000 nM) for central 5-HT1B sites.